CERSCERUS CORP

Nasdaq cerus.com


$ 1.62 $ -0.14 (-7.95 %)    

Friday, 03-May-2024 15:59:43 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.62
$ 2.00
$ 1.61 x 200
$ 1.64 x 200
$ 1.62 - $ 2.00
$ 1.21 - $ 3.08
2,509,244
na
294.99M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-09-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-maintains-overweight-on-cerus-raises-price-target-to-4

Cantor Fitzgerald analyst Ross Osborn maintains Cerus (NASDAQ:CERS) with a Overweight and raises the price target from $3 to...

 craig-hallum-initiates-coverage-on-cerus-with-buy-rating-announces-price-target-of-5

Craig-Hallum initiates coverage on Cerus (NASDAQ:CERS) with a Buy rating and announces Price Target of $5.

 perion-network-cuts-sales-outlook-joins-range-resources-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday.

 cerus-corporation-announces-fda-approval-of-extended-shelf-life-for-intercept-platelet-processing-sets-doubling-previous-shelf-life

Cerus Corporation (NASDAQ:CERS) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of 12-mon...

 cathie-woods-ark-invest-sells-another-tranche-of-block-shares-even-as-bitcoin-price-stages-a-recovery

On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CR...

 why-blood-components-focused-cerus-stock-is-rising-tuesday

Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in car...

Core News & Articles
Market-Moving News for March 19th
03/19/2024 12:41:16

CERS: 64% | Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; S...

 cathie-woods-ark-invest-sells-coinbase-shares-as-bitcoin-hits-yet-another-all-time-new-high-buys-stock-of-this-social-media-company

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc (NASDAQ:COIN) and Pinterest Inc ...

 stephens--co-reiterates-equal-weight-on-cerus-maintains-25-price-target

Stephens & Co. analyst Jacob Johnson reiterates Cerus (NASDAQ:CERS) with a Equal-Weight and maintains $2.5 price target.

 why-united-natural-foods-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

 cantor-fitzgerald-reiterates-overweight-on-cerus-maintains-3-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Cerus (NASDAQ:CERS) with a Overweight and maintains $3 price target.

 box-reports-upbeat-earnings-joins-american-public-education-wave-life-sciences-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

 cerus-q4-earnings-insights
Cerus: Q4 Earnings Insights
03/05/2024 21:20:06

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION